PRVA

PRVA

USD

Privia Health Group Inc. Common Stock

$22.700-0.260 (-1.132%)

Reaalajas hind

Healthcare
Health Information Services
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$22.960

Kõrge

$22.960

Madal

$22.010

Maht

0.01M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

2.8B

Tööstusharu

Health Information Services

Riik

United States

Kauplemisstatistika

Keskmine maht

0.78M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $16.37Praegune $22.700Kõrge $26.09

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 25. mai 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

PRVA: Privia Health Group Inc. Common Stock – A Look at Recent Performance and Future Signals

Stock Symbol: PRVA Generate Date: 2025-05-25 01:27:07

Let's break down what's been happening with Privia Health and what the tea leaves might be telling us.

Recent News Buzz

The vibe around Privia Health has been pretty positive lately. Just recently, on May 8th, the company announced some really strong first-quarter results for 2025. They're not just doing well, they're also expanding into Arizona, which is a big deal. What's more, they actually raised their full-year 2025 outlook across most metrics. That's a clear sign of confidence from management.

Before that, in late April, JMP Securities, a financial firm, reiterated their "Market Outperform" rating on Privia Health, keeping a $29 price target. When analysts stick by their positive ratings and price targets, it usually means they see continued strength or potential for growth. So, overall, the news flow paints a picture of a company executing well and getting a thumbs-up from the pros.

Price Check: What's the Stock Been Doing?

Looking at the last few months, PRVA's stock has seen its ups and downs, but there's a noticeable shift. Back in late February, it was hovering around the $24.50 mark. It then dipped through March and early April, even touching the low $21s. However, something changed around early May.

Right after that positive earnings report on May 8th, the stock jumped significantly, moving from around $22.85 to over $25.00 in a single day. It even hit a 52-week high of $26.09 on that day. Since then, it's pulled back a bit, trading in the $24-$25 range, and more recently, it's drifted down to around $22.86 as of May 23rd. This recent dip brings it very close to a key support level identified by our AI model at $22.85.

Now, for the future, our AI model from AIPredictStock.com is projecting some interesting moves:

  • Today's Prediction: A slight increase of 0.34%.
  • Next Day's Prediction: A more significant jump of 2.44%.
  • The Day After Next: Another positive move of 2.06%.

These predictions suggest a potential rebound and upward trend in the very near term, especially after the recent pullback.

Outlook & Ideas

Putting it all together, the situation for PRVA seems to lean towards a potential buying opportunity right now, especially for those with a medium-term view.

Here's why:

  • Strong Fundamentals & Positive News: The company is performing well, expanding, and raising its outlook. This fundamental strength often provides a good base for stock appreciation.
  • Analyst Confidence: A maintained "Market Outperform" rating and a $29 price target from JMP Securities show professional conviction.
  • AI's Short-Term Bullishness: The AI model is predicting an upward trend for the next few days, which aligns with the idea that the recent dip might be temporary. The fact that the current price is very close to a strong support level ($22.85) is also a key technical signal.

Potential Entry Consideration: Given the current price of $22.86 and the identified support level of $22.85, this area could be considered a compelling entry point. The AI's prediction of an upward trend starting today and continuing for the next couple of days further supports this. Another potential entry point could be around $22.95.

Potential Exit/Stop-Loss Consideration:

  • For taking profits, the AI projects a potential target price of $25.68. This aligns with the stock's recent high and could be a reasonable area to consider. Another take-profit level could be $24.28.
  • To manage risk, a stop-loss order placed below a recent low or a key support level is wise. Our model suggests a stop-loss at $20.58. This helps protect against unexpected downside if the positive signals don't play out.

Company Context

It's worth remembering that Privia Health Group Inc. operates in the Health Information Services sector, essentially helping physician practices, health plans, and health systems run more efficiently and improve patient care. Their business model focuses on technology, management services, and value-based care. So, when they report strong financial results and expand into new states like Arizona, it directly reflects the success of their core strategy in a growing healthcare market.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and you could lose money. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions.

Seotud uudised

Analyst Upgrades

JP Morgan Maintains Overweight on Privia Health Gr, Raises Price Target to $32

JP Morgan analyst Lisa Gill maintains Privia Health Gr with a Overweight and raises the price target from $29 to $32.

Vaata rohkem
JP Morgan Maintains Overweight on Privia Health Gr, Raises Price Target to $32
Analyst Upgrades

Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $24

Barclays analyst Andrew Mok maintains Privia Health Gr with a Equal-Weight and raises the price target from $23 to $24.

Vaata rohkem
Barclays Maintains Equal-Weight on Privia Health Gr, Raises Price Target to $24
GlobeNewswire

Privia Health Reports First Quarter 2025 Financial Results

Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May

Vaata rohkem
Privia Health Reports First Quarter 2025 Financial Results

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 12. juuni 2025, 21:26

LangevNeutraalneTõusev

70.7% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Mõõdukas
Kauplemisjuhend

Sisenemispunkt

$23.02

Võta kasum

$24.30

Peata kahjum

$20.70

Põhitegurid

DMI näitab langustrendi (ADX:21.4, +DI:7.2, -DI:8.3), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($22.97) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 7.1x keskmisest (7,285), mis viitab äärmiselt tugevale ostusurvele
MACD -0.0457 on signaalijoone -0.0523 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.